CLINICAL UNIT BASED RESEARCH
Alcohol and Drug Abuse Treatment Program
Publications and Presentations
Greenfield, Shelly. The NIDA Clinical Trials Network: Bridging the Gap Between Research and Practice. AAAP News. Vol. XVIII, No. 3. Fall 2003.
Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug Alcohol Depend.¬† [An article resulting from the work of the Gender Special Interest Group chaired by Dr. Greenfield]¬† Included in NIDA CTN Dissemination Library http://ctndisseminationlibrary.org/faq.htm Drug Alcohol Depend. 2007 Jan 5;86(1):1-21.
McCarty D, Fuller BE, Arfken C, Miller M, Nunes E, Edmundson D, Copersino M, Floyd A, Forman R, Laws R, Magruder KM, Oyama M, Prather K, Sindelar J, Wendt WW.¬† Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs.¬† Psychiatric Services. February 2007. Vol 58. No. 2., pgs 181 ‚Äď 190.
McCarty D, Fuller B, Kaskutas LA, Wendt WW, Nunes EV, Miller M, Forman R, Magruder KM, Arfken C, Copersino M, Floyd A, Sindelar J, Edmundson E. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug Alcohol Depend. 2007 Sep 15
Forman R, Crits-Christoph P, Kaynak O, Worley M, Hantula DA, Kulaga A, Rotrosen J, Chu M, Gallop R, Potter J, Muchowski P, Brower K, Strobbe S, Magruder K, Chellis AH, Clodfelter T, Cawley M. A feasibility study of a web-based performance improvement system for substance abuse treatment providers. J Subst Abuse Treat. 2007 Dec;33(4):363-71. Epub 2007 May 14.
Gordon SM, Johnson JA, Greenfield SF, Cohen L, Killeen T, Roman PM. Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv. 2008 Sep;59(9):1056-9.
Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS Jr, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, Ling W. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. Drug Alcohol Depend. 2008 Sep 19. [Epub ahead of print]
Woody, MD; Sabrina A. Poole, MS; Geetha Subramaniam, MD; Karen Dugosh, PhD; Michael Bogenschutz, MD; Patrick Abbott, MD; Ashwin Patkar, MD; Mark Publicker, MD; Karen McCain, MSN, FNP; Jennifer Sharpe Potter, PhD, MPH; Robert Forman, PhD; Victoria Vetter, MD; Laura McNicholas, MD, PhD; Jack Blaine, MD; Kevin G. Lynch, PhD; Paul Fudala, PhD Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth. A Randomized Trial. JAMA. 2008;300(17):2003-2011.
Tracy, Kathlene, Brown, Lawrence S., Kritz, Steven, Alderson, Donald, Robinson, Jim, Bini, Edmund J., Levy, Michael, Calsyn, Donald, Rieckmann, Traci, Fuller, Bret, McAuliffe, Pat and Rotrosen, John (2009) 'Substance Abuse Treatment Clinician Opinions and Infectious Disease Service Delivery', Journal of Addictive Diseases, 28:1,8 - 12
Jaffee, William B., Bailey, Genie L., Lohman, Michelle, Riggs, Paula, McDonald, Leah, Weiss, Roger D.¬† Methods of Recruiting Adolescents with Psychiatric and Substance Use Disorders for a Clinical Trial.¬† American Journal of Drug and Alcohol Abuse 2009;35(5):381-384
Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD. Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA Clinical Trials Network study. Drug Alcohol Depend. 2009 Nov 28. [Epub ahead of print]
Potter JS, Prather K, Kropp F, Byrne M, Sullivan CR, Mohamedi N, Copersino ML, Weiss RD. A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. Contemp Clin Trials. 2010 Jan 13. [Epub ahead of print]
Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology.¬† Contemp Clin Trials. 2010 Jan 29. [Epub ahead of print]
Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network. J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S80-6.PMID: 20307799 [PubMed - in process]
Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B. From research to the real world: buprenorphine in the decade of the Clinical Trials Network. J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S53-60.PMID: 20307796 [PubMed - in process]
Campbell BK, Tillotson CJ, Choi D, Bryant K, DiCenzo J, Provost SE, Zammarelli L, Booth RE, McCarty D. Predicting outpatient treatment entry following detoxification for injection drug use: the impact of patient and program factors. J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S87-96.PMID: 20307800 [PubMed - in process]
Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE. HIV Risk Behavior in Treatment-Seeking Opioid-Dependent Youth: Results From a NIDA Clinical Trials Network Multisite Study. J Acquir Immune Defic Syndr. 2010 Apr 13. [Epub ahead of print] PMID: 20393347 [PubMed - as supplied by publisher]
Brooks A, Meade CS, Potter JS, Lokhnygina Y, Calsyn DA, Greenfield SF. Gender Differences in the Rates and Correlates of HIV Risk Behaviors Among Drug Abusers. Subst Use Misuse. 2010 Jun 10. [Epub ahead of print] PMID: 20536356 [PubMed - as supplied by publisher]
Upadhyay J, Maleki N, Potter J, Elman I, Rudrauf D, Knudsen J, Wallin D, Pendse G, McDonald L, Griffin M, Anderson J, Nutile L, Renshaw P, Weiss R, Becerra L, Borsook D. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain. 2010 Jul;133(Pt 7):2098-114. Epub 2010 Jun 16. PMID: 20558415 [PubMed - in process]
Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, Covey LS, Croghan IT, Adler LA, Weiss RD, Leimberger JD, Lewis DF, Dorer EM. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2010 May 18. [Epub ahead of print] PMID: 20492837 [PubMed - as supplied by publisher]
Weiss RD, Potter JS, Copersino ML, Prather K, Jacobs P, Provost S, Chim D, Selzer J, Ling W. ¬†Conducting clinical research with prescription opioid dependence: defining the population. Am J Addict. 2010 Mar;19(2):141-6.PMID: 20163386
Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D.¬† Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. ¬†J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):903-14. Epub 2011 Aug
Carroll KM, Ball SA, Jackson R, Martino S, Petry NM, Stitzer ML, Wells EA, Weiss RD. Ten Take Home Lessons from the First 10 Years of the CTN and 10 Recommendations for the Future. ¬†Am J Drug Alcohol Abuse. 2011 Sep;37(5):275-82.
Greenfield SF, Rosa C, Putnins SI, Green CA, Brooks AJ, Calsyn DA, Cohen LR, Erickson S, Gordon SM, Haynes L, Killeen T, Miele G, Tross S, Winhusen T. Gender research in the national institute on drug abuse national treatment clinical trials network: a summary of findings. Am J Drug Alcohol Abuse. 2011 Sep;37(5):301-12. PMCID: PMC3160726 [Available on 2012/9/1]
Potter JS, Donovan DM, Weiss RD, Gardin J, Lindblad R, Wakim P, Dodd D. Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection. Am J Drug Alcohol Abuse. 2011 Sep;37(5):400-7. PMCID: PMC3160724 [Available on 2012/9/1]
Svikis DS, Keyser-Marcus L, Stitzer M, Rieckmann T, Safford L, Loeb P, Allen T, Luna-Anderson C, Back SE, Cohen J, Debernardi MA, Dillard B, Forcehimes A, Jaffee W, Killeen T, Kolodner K, Levy M, Pallas D, Perl HI, Potter JS, Provost S, Reese K, Sampson RR, Sepulveda A, Snead N, Wong CJ, Zweben J. Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders.¬† Drug Alcohol Depend. 2011 Jul 29. [Epub ahead of print]
Hamdi NR, Levy M, Jaffee WB, Chisholm SM, Weiss RD. Implementing an adapted version of the job seekers' workshop in a residential program for patients with substance use disorders. J Addict Med. 2011 Jun;5(2):148-52. PMCID: PMC3107016 [Available on 2012/6/1]
Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. Arch Gen Psychiatry. 2011 Nov 7. [Epub ahead of print] PMID: 22065255 [PubMed - as supplied by publisher]
Kolodziej ME, Muchowski PM, Hamdi NR, Morrissette P, McGowan AJ, Weiss RD. Adaptation of the patient feedback survey at a community treatment setting. Am J Addict. 2012 Jan;21(1):63-71. doi: 10.1111/j.1521-0391.2011.00197.x. Epub 2011 Dec 15. PMID: 22211348 [PubMed - in process]
Tiffany ST, Friedman L, Greenfield SF, Hasin DS, Jackson R. Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders.¬† Addiction. 2011 Oct 7. doi: 10.1111/j.1360-0443.2011.03581.x. [Epub ahead of print]
Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG, Hamilton JA, Huestis MA, Hughes JR, Lindblad R, Marlatt GA, Preston KL, Selzer JA, Somoza EC, Wakim PG, Wells EA. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials.¬† Addiction. 2012 Apr;107(4):694-708. doi: 10.1111/j.1360-0443.2011.03473.x. Epub 2011 Jul 22.¬†
Morrissette PM, Muchowski P, Sollenberger J. The value of patient feedback: what our patients tell us when we listen. Paradigm. 16(3): 6-8, Spring 2012.
Warden D, Subramaniam GA, Carmody T, Woody GE, Minhajuddin A, Poole SA, Potter J, Fishman M, Bogenschutz M, Patkar A, Trivedi MH.¬† Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.¬† Addict Behav. 2012 May 8. [Epub ahead of print]
Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD.¬† Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.¬† Drug Alcohol Depend. 2013 Jan 18. doi:pii: S0376-8716(12)00486-3. 10.1016/j.drugalcdep.2012.12.010. [Epub ahead of print]
McHugh RK, Devito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD.¬† Gender differences in a clinical trial for prescription opioid dependence.¬† J Subst Abuse Treat. 2013 Jan 10. doi:pii: S0740-5472(12)00455-2. 10.1016/j.jsat.2012.12.007. [Epub ahead of print]
Brooks AJ, Lokhnygina Y, Meade CS, Potter JS, Calsyn DA, Greenfield SF.¬† Racial/Ethnic Differences in the Rates and Correlates of HIV Risk Behaviors among Drug Abusers.¬† Am J Addict. 2013 Mar;22(2):136-47. doi: 10.1111/j.1521-0391.2013.00303.x.¬† PMCID: PMC3576857[Available on 2013/3/1]
Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, Woody GE, Weiss RD.¬† Association of cannabis use with opioid outcomes among opioid-dependent youth.¬† Drug Alcohol Depend. 2013 Mar 22. doi:pii: S0376-8716(13)00089-6. 10.1016/j.drugalcdep.2013.02.030. [Epub ahead of print]
Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ.¬† Benzodiazepine use during buprenorphine treatment for opioid dependence: Clinical and safety outcomes. Drug Alcohol Depend. 2013 Oct 1;132(3):580-6. doi: 10.1016/j.drugalcdep.2013.04.006. Epub 2013 May 18
Griffin ML, Dodd DR, Potter JS, Rice LS, Dickinson W, Sparenborg S, Weiss RD. Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. Am J Drug Alcohol Abuse. 2013 Nov 12. [Epub ahead of print]
Meade CS, Bevilacqua LA, Moore ED, Griffin ML, Gardin JG 2nd, Potter JS, Hatch-Maillette M, Weiss RD.¬†¬† Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence. Am J Addict. 2014 Jan-Feb;23(1):27-33. doi: 10.1111/j.1521-0391.2013.12057.x. Epub 2013 Jul 29.
McHugh RK, Hu MC, Campbell AN, Hilario EY, Weiss RD, Hien DA.¬† Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disorders. J Trauma Stress. 2014 Feb;27(1):82-9. doi: 10.1002/jts.21878. Epub 2014 Jan 28.
Gastfriend, David. Patient Treatment Matching: What Works for Whom and Why. Harvard Medical School/Cambridge Hospital Addictions Conference. March 5, 2004.
Amaro, Hortensia. Treatment Improvement Through Applied Research in Community Based Service Settings. National Institute on Drug Abuse ‚Äď Smart Practice, Practical Science: Blending Treatment and Research. Miami Beach, Florida. June 6, 2005.
Najavits, Lisa. Seeking Safety: A Psychotherapy Model for PTSD and Addiction. Harvard Medical School/Cambridge Hospital Addictions Conference. March 5, 2005.
G. Bailey, W. Jaffee, R. Weiss, M. Lohman, and P. Riggs. Adolescents with Attention Deficit Disorders and Co-Occurring Substance Use Disorders: Referral Sources and Recruitment in a Multi-Site Clinical Trial. CPDD 2008 Annual Meeting. San Juan Puerto Rico, June 17, 2008. Abstract# 41
R. D. Weiss, J.S. Potter, K. Prather, S. Provost, J. Selzer, and W. Ling. Methodological Issues in Designing a Clinical Trial for Opioid Analgesic Dependence: Defining the Population. CPDD 2008 Annual Meeting. San Juan Puerto Rico, June 16, 2008. Abstract# 790
M.E. Kolodziej, P.M. Muchowski, and R.F. Forman. Assessment of Patients' Feedback Concerning Outpatient Substance Abuse Treatment [Poster]. American Psychological Association (APA) 116th Annual Convention. Boston, MA, August 16, 2008.
Potter JS, Meade CS, Peterson AT. A Systematic Review of Gender Differences in HIV Sexual Risk Behaviors Among Stimulant and Opioid Abusers. 71st Annual Meeting of the College on Problems of Drug Dependence. Reno/Sparks, Nevada June 20-25, 2009 Abstract# 481
Brooks A, CS Meade, Potter JS, Lokhnygina Y, Calsyn D, Greenfield S. Gender differences in HIV Risk Behaviors Among Drug Abusers. 71st Annual Meeting of the College on Problems of Drug Dependence. Reno/Sparks, Nevada June 20-25, 2009
Weiss RD, Potter JS, Byrne M, Sullivan C, Ling W. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. 71st Annual Meeting of the College on Problems of Drug Dependence. Reno/Sparks, Nevada June 20-25, 2009 Abstract# 654
Winhusen T, Somoza E, Brigham G, Liu D, Green C, Covey L, Croghan I, Adler L, Weiss R, Leimberger J, Lewis D, Dorer E. A Double-Blind Placebo-Controlled Trial of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with Attention Deficit Hyperactivity Disorder. 71st Annual Meeting of the College on Problems of Drug Dependence. Reno/Sparks, Nevada June 20-25, 2009
Provost SE, Potter JS, Weiss RD, Jacobs P, Ling W.¬† A community-based, two-phase randomized controlled trial of buprenorphine with and without individual drug counseling for the treatment of opioid analgesic addiction.¬† Poster presentation as part of the 25th Anniversary of Alcohol Tobacco & Other Drugs Section and 10th Anniversary of the National Institute on Drug Abuse Clinical Trials Network at the American Public Health Association (APHA) Annual Meeting & Exposition, Denver, CO, November 9, 2010.
Weiss RD, Potter JS, Griffin M., Connery H., Ling W.,¬† Predictors of outcome in the multi-site CTN Prescription Opioid Addiction Treatment Study Poster presented at CPDD 73rd Annual Meeting • Hollywood, Florida, June 20, 2011
Carroll KM. "State of the science on measuring drug use:¬† Self-report".¬† In C. Rosa (Chair), A systematic approach to selection and measurement in clinical trials research.¬† Workshop conducted at the 73rd Annual Scientific Meeting, College of Problems on Drug Dependence.¬† Hollywood, Fl:¬† 22 June 2011.
Carroll, KM.Top 10 CTN Accomplishments in Behavioral Therapies in the Past 10 Years¬† 2011. NIATx Summit and The State Associations of Addiction Services (SAAS) Conference, Boston, MA, July 13, 2011
Weiss RD.What the National Institute on Drug Abuse's Clinical Trials Network Can Do for You¬† 2011. NIATx Summit and The State Associations of Addiction Services (SAAS) Conference, Boston, MA, July 13, 2011
Levy, M. NIATX and the CTN: It's All About Improving Care. 2011 NIATx Summit and The State Associations of Addiction Services (SAAS) Conference , Boston, MA July 13, 2011
Provost S, Potter JS, Weiss RD.¬† Advances in Clinical Research for Prescription Opioid Dependence.¬† 12th Biennial Massachusetts NASW Social Work Symposium.¬† Framingham, MA, March 30, 2012.
R. McHugh, S. F. Greenfied, J. S. Potter, H. S. Connery, R. D.Weiss,¬† Gender differences in clinical characteristics of prescription-opioid-dependent patients Presented at the 74th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 9-14, 2012, Palm Springs, CA Abstract# 431
S. Nielsen, M. Hillhouse, L. Mooney, J. Sharpe Potter, R.Weiss, J. Lee, W. Ling, Buprenorphine induction for prescription opioid users: Findings from the Prescription Opiate Addiction Treatment Study (POATS) Presented at the 74th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 9-14, 2012, Palm Springs, CA Abstract# 482
R.Weiss, M. L. Griffin, J. Potter, H. Connery Quality of life over time in the multi-site CTN Prescription Opioid Addiction Treatment Study Presented at the 74th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 9-14, 2012, Palm Springs, CA Abstract# 709
S. Sparenborg, L. Hu, J. Sharpe Potter, R.Weiss Pre-existing psychiatric severity did not affect likelihood of success in the Prescription Opiate Addiction Treatment Study (POATS) Presented at the 74th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 9-14, 2012, Palm Springs, CA Abstract# 638
Kiluk, BD. Dreifuss, J. Caroll, KM. The Short Inventory of Problems ‚Äď Revised (SIP-R): Psychometric Properties in English and Spanish Speaking Populations.¬†¬† Presented at the 74th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 9-14, 2012, Palm Springs, CA Abstract# 316
Weiss RD: The prescription opioid addiction treatment study: secondary analyses, presented at the 44th annual medical-scientific conference of the American Society of Addiction Medicine, April 25-28, 2013, Chicago, IL
Weiss RD: Patient Characteristics that Predict Buprenorphine-Naloxone Treatment Outcome for Prescription Opioid Dependence: Results From a Multi-Site Study. APA 166th Annual Meeting, San Francisco, CA, May 21, 2013
Griffin ML, Dodd D, Rice LS, Weiss RD: Characteristics and Treatment Outcomes in Prescription Opioid‚ÄďDependent Patients With and Without Co-Occurring Psychiatric Disorder. Paper presented at the 166th Annual
Meeting of the American Psychiatric Association (APA), San Francisco, CA, May 21, 2013
Hill, KP. Griffin, ML. Connery, HS.¬† Fitzmaurice, GM.¬† Subramaniam, G.¬† Woody, GE.¬† Weiss R.¬† Lack of Association of Cannabis Use with Opioid Outcomes Among Opioid-Dependent Youth.¬†¬† Presented at the 75th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 15-20, 2013, San Diego, CA Abstract# 248Stotts, A.¬† Northrup, T.¬† Potter, JS.¬† Marino, EN.¬† Walker, R.¬† Trivedi, M.¬† Weiss, R.¬† ¬†Relations between Craving and Withdrawal and Time to First Opioid Use Among Prescription Opioid Abusers Initiating Buprenorphine Detoxification.¬† Presented at the 75th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 15-20, 2013, San Diego, CA Abstract# 623
Weiss, R.¬† Griffin, ML.¬† Dreifuss, JA.¬† Dodd, D.¬† Potter, JS.¬† Connery, H.¬†¬†¬† Who Benefits from More Intensive Counseling for Prescription Opioid Dependence?¬† Presented at the 75th Annual Scientific Meeting of the College on Problems of Drug Dependence, June 15-20, 2013, San Diego, CA Abstract# 688
Weiss RD. Treatment of Prescription Opioid Dependence, Hazelden Foundation, Center City, MN, June 27, 2013
Weiss RD.¬† Treatment of Prescription Opioid Dependence, Grand Rounds at North Shore Medical Center, Salem, MA, September 27, 2013
Griffin M, Dodd D, Rice L, Weiss RD.¬† Characteristics and Treatment Outcomes in Prescription Opioid-Dependent Patients with and without Co-Occurring Psychiatric Disorder.¬† III International Congress Dual Disorders.¬† Barcelona, Spain, October 25, 2013